Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?

Publication/Presentation Date

1-1-2017

Abstract

This is a case of a 54-year-old female with a history of mechanical aortic valve replacement who presented in cardiogenic shock. Her primary care provider started her on rivaroxaban for anticoagulation therapy. An urgent transesophageal echocardiogram revealed a significant gradient and thrombosis on one leaflet of the valve that was immobile. Given that she was not a surgical candidate, she underwent thrombolysis. However, she later died due to complications from the thrombotic valve. The utility of target-specific oral anticoagulants has yet to be established in clinical practice.

Volume

13

Issue

2

First Page

73

Last Page

75

ISSN

1947-6108

Disciplines

Medicine and Health Sciences

PubMedID

28740586

Department(s)

Department of Medicine, Cardiology Division

Document Type

Article

Share

COinS